LEADER 03871nam 22005415 450 001 9910300439903321 005 20221121232947.0 010 $a981-10-7596-4 024 7 $a10.1007/978-981-10-7596-4 035 $a(CKB)4100000001795049 035 $a(DE-He213)978-981-10-7596-4 035 $a(MiAaPQ)EBC5255554 035 $a(PPN)223954306 035 $a(EXLCZ)994100000001795049 100 $a20180130d2018 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aEarly-stage Lung Cancer $eScreening and Management /$fedited by Xiangpeng Zheng, Ming Li, Guozhen Zhang 205 $a1st ed. 2018. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2018. 215 $a1 online resource (XXIV, 423 p. 181 illus. in color.) 311 $a981-10-7595-6 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aThe pathological advances of early lung adenocarcinoma -- Advancement in Cross-sectional Anatomy of the Lung -- Low-dose CT Screening of Lung Cancer -- The Advances of PET/CT clinical application in micronodular lung cancer -- Angiogenesis-dependent tumor progression -- Pure Ground-glass Nodules -- Part-solid Ground-glass Nodules -- Solid Pulmonary Nodules -- CT-based Categorization of Small Pulmonary Adenocarcinoma and Differential Diagnosis -- Multiple Primary Lung Cancer -- Management Strategies of Micronodular Lung Cancer: Surgical Perspectives -- Management Strategies of Early-stageLung Cancer: Stereotactic Ablative Radiation Therapy -- Radiofrequency ablation -- Case Discussion. 330 $aThis book discusses major issues and advances in the diagnosis and treatment of incidentally detected early-stage lung cancer (ESLC). In Part I, pathology and radiology experts comprehensively review the state-of-the-art advances in individual research fields, and offer an update on the cross-sectional anatomy of the lung and post-processing techniques for CT imaging. Part II focuses on the imaging features, differential diagnosis and radiologic-pathologic correlations of ESLCs in the categories pGGN, mGGN and solid nodules in compliance with the Guidelines on Lung Cancer Screening from the National Comprehensive Cancer Network (NCCN). Part III briefly introduces therapeutic management strategies for ESLCs, including surgical and non-surgical approaches, for instance stereotactic ablative radiation therapy (SABR) and radiofrequency ablation (RFA). Lastly, the authors have meticulously prepared 50 clinical cases of pathologically proven benign and malignant pulmonary nodules with in-depth discussion and experts? comments to further readers? understanding of practical imaging and management strategies of ESLCs. 606 $aRespiratory organs?Diseases 606 $aRadiology 606 $aOncology 606 $aPneumology/Respiratory System$3https://scigraph.springernature.com/ontologies/product-market-codes/H33134 606 $aDiagnostic Radiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H29013 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aRespiratory organs?Diseases. 615 0$aRadiology. 615 0$aOncology. 615 14$aPneumology/Respiratory System. 615 24$aDiagnostic Radiology. 615 24$aOncology. 676 $a616.2 702 $aZheng$b Xiangpeng$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aLi$b Ming$c(Of Shanghai Hua dong yi yuan),$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aZhang$b Guozhen$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300439903321 996 $aEarly-stage Lung Cancer$91744487 997 $aUNINA